Tag : Study

CCT Impact

Goodness Growth Holdings™ Subsidiary Resurgent Biosciences Launches First IRB-Approved Research Study on Entheogens & Psychedelic Experiences

CCT IMPACT Agent
Goodness Growth Holdings, Inc. (“Goodness Growth” or the “Company”) (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP incubator, today announced that its subsidiary, Resurgent Biosciences, Inc. (“Resurgent”), is actively recruiting 100 participants to take part in an anonymous online survey to research the varying effects of entheogen and psychedelic......
CCT Impact

Chemistree Investee ImmunoFlex™ Completes Clinical Study and Submits US and International Patent Applications

CCT IMPACT Agent
Chemistree Technology Inc. (CSE: CHM) (CSE: CHM.WT) (OTCQB: CHMJF) (the “Company” or “Chemistree”) is pleased to confirm that investee company ImmunoFlex Therapeutics Inc. (“ImmunoFlex”™), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. The exploratory trial was the latest of several small trials where......
CCT Impact

Study: Azuca TiME INFUSION™ Helps Reduce Waste, Save Money & Improve Efficiencies in Edibles Manufacturing

CCT IMPACT Agent
Azuca, the leading all-natural, fast-acting cannabis edibles ingredient brand, today released its new white paper, Stability and Waste Solutions for Edibles Manufacturers. The study reveals that Azuca’s proprietary technology, TiME INFUSION™, not only offers solutions for fast onset and offset consumption, but also helps manufacturers by improving production cost and efficiency by......
CCT Impact

ArthroCBD Shares Study’s Findings for Arthritis Awareness Month

CCT IMPACT Agent
Arthritis is one of the most widespread health conditions in the United States and affects one in four adults, according to the CDC. That’s over 54 million men and women. There are common misconceptions around Arthritis, including what it’s like to live with it. ArthroCBD recently performed quantitative and qualitative studies to “debunk” these......
CCT Impact

Khiron Comments on the Results of Project Twenty21 – UK´s Largest Observational Study into Medical Cannabis Products

CCT IMPACT Agent
Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, applauds the publication today in the accredited scientific journal “Psychopharmacology” of the first findings arising from Project Twenty 21, UK’s first and largest national medical cannabis registry that......
CCT Impact

New Study Finds People Turned to Cannabis During the Pandemic to Feel Happier

CCT IMPACT Agent
Did the stressors of COVID-19 drive more Americans to use medical cannabis as an alternative tool for managing their mental health? A new national study exploring this question found a positive correlation between national demand for medical cannabis and the national number of COVID-19 cases; in other words, as cases......
CCT Impact

Prospect Farms and Radicle Science Launch Study to Scientifically Evaluate the Impact of CBD on Sleep

CCT IMPACT Agent
Prospect Farms, the premium seed-to-store wellness brand offering full-spectrum CBD products to help people and pets live well, naturally, has announced the launch of their observational study to scientifically evaluate and research the impact of CBD on sleep. In partnership with Radicle Science, led by Dr. Jeffrey Chen MD/MBA, Founder and Former......
CCT Impact

Global Widget part of first-of-its-kind industrywide clinical study reporting no evidence of liver toxicity in adults using CBD

CCT IMPACT Agent
Global Widget, the manufacturer and distributor of iconic CBD brands Hemp Bombs®, Nature’s Script™ and Perfect Paws Hemp™, is one of 12 CBD companies whose customers took part in a recent Validcare clinical investigation that reports no preliminary evidence of liver disease in the over 800 adults taking CBD as part of the......
CCT Impact

Study: New Yorkers Support Recreational Marijuana, Just Not in Their Neighborhood

CCT IMPACT Agent
While 61% of New York State residents support the legalization of adult-use recreational marijuana sales, more than half (52%) of those living in New York City would oppose its sale in their neighborhood. This disparity between general support and willingness to actually live near one is a significant problem when communities decide where, if......
CCT Impact

Stero Biotechs report initial results in the Exploratory Study it supports of CBD-based treatment for Covid-19 severe patients

CCT IMPACT Agent
Stero Biotechs, an Israel-based, clinical-stage company focused on Cannabidiol (CBD) formulation research and development, reports initial results in the clinical trial it supports. The clinical trial, covered by Stero’s IP for CBD Treatment of Severe and Critical COVID-19 Pulmonary Infection, is conducted at Rabin Medical Center, the leading hospital of Clalit......